Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
36,645,106
-
Share change
-
-1,954,551
-
Total reported value
-
$395,680,950
-
Price per share
-
$10.80
-
Number of holders
-
148
-
Value change
-
-$19,907,623
-
Number of buys
-
78
-
Number of sells
-
71
Institutional Holders of SCICLONE PHARMACEUTICALS INC - COM (SCLN) as of Q4 2016
As of 31 Dec 2016,
SCICLONE PHARMACEUTICALS INC - COM (SCLN) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,645,106 shares.
The largest 10 holders included
BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, Nantahala Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, Stonepine Capital Management, LLC, and Numeric Investors LLC.
This page lists
148
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.